Addex Therapeutics Ltd
ADXN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,195 | $3,150 | $4,385 | $32,609 |
| - Cash | $3,342 | $3,865 | $6,957 | $20,485 |
| + Debt | $42 | $344 | $373 | $482 |
| Enterprise Value | $1,895 | -$371 | -$2,199 | $12,606 |
| Revenue | $404 | $1,613 | $1,422 | $2,916 |
| % Growth | -74.9% | 13.4% | -51.2% | – |
| Gross Profit | $404 | $1,613 | $1,422 | $2,916 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$4,646 | -$2,190 | -$10,453 | -$14,941 |
| % Margin | -1,149.6% | -135.8% | -734.9% | -512.3% |
| Net Income | $7,056 | -$10,556 | -$20,804 | -$15,352 |
| % Margin | 1,746% | -654.5% | -1,462.6% | -526.4% |
| EPS Diluted | 8.4 | -16.8 | -55.2 | -54 |
| % Growth | 150% | 69.6% | -2.2% | – |
| Operating Cash Flow | -$5,374 | -$7,992 | -$16,437 | -$14,705 |
| Capital Expenditures | -$1 | -$7 | -$1 | -$32 |
| Free Cash Flow | -$5,375 | -$7,999 | -$16,438 | -$14,737 |